US Stock MarketDetailed Quotes

SCNI Scinai Immunotherapeutics

Watchlist
  • 3.245
  • -0.015-0.46%
Close Dec 4 16:00 ET
2.77MMarket Cap1.35P/E (TTM)

Scinai Immunotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-83.78%1.03M
-59.02%3.08M
-55.31%4.83M
-65.40%4.87M
-65.40%4.87M
-22.99%6.36M
-34.02%7.51M
-29.73%10.8M
-18.99%14.08M
-18.99%14.08M
-Cash and cash equivalents
-83.78%1.03M
-59.02%3.08M
-55.31%4.83M
-65.40%4.87M
-65.40%4.87M
-22.99%6.36M
-34.02%7.51M
-29.73%10.8M
-18.99%14.08M
-18.99%14.08M
Receivables
96.49%448K
221.01%443K
142.02%288K
232.73%366K
232.73%366K
13.97%228K
-23.46%138K
-38.85%119K
12.24%110K
12.24%110K
-Accounts receivable
--120K
--119K
----
----
----
----
----
----
----
----
-Other receivables
43.86%328K
134.78%324K
142.02%288K
232.73%366K
232.73%366K
13.97%228K
-23.46%138K
-38.85%119K
12.24%110K
12.24%110K
Prepaid assets
----
----
----
57.78%71K
57.78%71K
----
----
----
-80.26%45K
-80.26%45K
Restricted cash
12.30%137K
9.52%138K
10.24%140K
0.00%140K
0.00%140K
--122K
--126K
--127K
-2.10%140K
-2.10%140K
Total current assets
-75.91%1.62M
-52.93%3.66M
-52.43%5.25M
-62.09%5.45M
-62.09%5.45M
-20.67%6.71M
-32.77%7.77M
-29.03%11.05M
-19.46%14.37M
-19.46%14.37M
Non current assets
Net PPE
-10.33%10.64M
-7.69%11.19M
-3.67%11.8M
-5.29%12.03M
-5.29%12.03M
-2.95%11.87M
-5.33%12.13M
-13.63%12.25M
-10.54%12.7M
-10.54%12.7M
-Gross PPE
-10.33%10.64M
-7.69%11.19M
-3.67%11.8M
-1.89%14.83M
-1.89%14.83M
-2.95%11.87M
-5.33%12.13M
-13.63%12.25M
-7.39%15.12M
-7.39%15.12M
-Accumulated depreciation
----
----
----
-15.99%-2.81M
-15.99%-2.81M
----
----
----
-13.61%-2.42M
-13.61%-2.42M
Total non current assets
-10.33%10.64M
-7.69%11.19M
-3.67%11.8M
-5.29%12.03M
-5.29%12.03M
-5.06%11.87M
-7.35%12.13M
-15.37%12.25M
-10.54%12.7M
-10.54%12.7M
Total assets
-34.02%12.26M
-25.36%14.85M
-26.79%17.05M
-35.45%17.47M
-35.45%17.47M
-11.36%18.58M
-19.27%19.9M
-22.45%23.29M
-15.51%27.07M
-15.51%27.07M
Liabilities
Current liabilities
Payables
-11.07%1.03M
-12.45%1.31M
-28.76%1.54M
-25.28%535K
-25.28%535K
27.05%1.16M
31.16%1.49M
-10.81%2.16M
-28.33%716K
-28.33%716K
-accounts payable
-21.25%430K
1.08%658K
-29.32%928K
-25.28%535K
-25.28%535K
84.64%546K
9.88%651K
1.82%1.31M
-28.33%716K
-28.33%716K
-Other payable
-1.97%598K
-22.89%650K
-27.90%610K
----
----
-0.68%610K
54.21%843K
-25.21%846K
----
----
Current accrued expenses
----
----
----
-31.53%849K
-31.53%849K
----
----
----
15.89%1.24M
15.89%1.24M
Current debt and capital lease obligation
-4.71%364K
-7.61%364K
-7.86%387K
3.66%396K
3.66%396K
-31.96%382K
-93.01%394K
66.58%420K
1.87%382K
1.87%382K
-Current capital lease obligation
-4.71%364K
-7.61%364K
-7.86%387K
3.66%396K
3.66%396K
19.64%382K
59.63%394K
66.58%420K
1.87%382K
1.87%382K
Current liabilities
-9.49%1.39M
-11.44%1.67M
-25.36%1.93M
-23.87%1.78M
-23.87%1.78M
4.53%1.54M
-72.13%1.89M
-3.51%2.58M
-4.34%2.34M
-4.34%2.34M
Non current liabilities
Long term debt and capital lease obligation
-95.56%863K
-15.52%20.46M
-11.45%20.24M
-4.70%20.17M
-4.70%20.17M
15.35%19.43M
46.27%24.22M
2.74%22.86M
-26.04%21.16M
-26.04%21.16M
-Long term debt
-98.49%280K
-14.91%19.82M
-10.71%19.51M
-3.56%19.37M
-3.56%19.37M
19.70%18.6M
55.66%23.29M
6.63%21.85M
-26.07%20.08M
-26.07%20.08M
-Long term capital lease obligation
-29.16%583K
-30.96%640K
-27.38%732K
-26.07%797K
-26.07%797K
-36.63%823K
-41.86%927K
-42.59%1.01M
-25.45%1.08M
-25.45%1.08M
Derivative product liabilities
-99.04%3K
-99.67%3K
--0
-98.20%96K
-98.20%96K
--311K
--902K
--2.66M
--5.33M
--5.33M
Total non current liabilities
-95.61%866K
-18.54%20.46M
-20.69%20.24M
-23.51%20.26M
-23.51%20.26M
17.02%19.74M
51.47%25.12M
14.56%25.52M
-7.41%26.49M
-7.41%26.49M
Total liabilities
-89.39%2.26M
-18.05%22.14M
-21.12%22.17M
-23.54%22.04M
-23.54%22.04M
16.01%21.27M
15.63%27.01M
12.63%28.1M
-7.17%28.83M
-7.17%28.83M
Shareholders'equity
Share capital
--5.63M
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
--5.63M
----
----
----
----
----
----
----
----
----
Retained earnings
3.91%-115.31M
-3.01%-126.82M
-4.31%-124.49M
-5.61%-122.34M
-5.61%-122.34M
-11.59%-120.01M
-10.44%-123.11M
-1.46%-119.35M
-5.27%-115.84M
-5.27%-115.84M
Paid-in capital
1.99%121.43M
3.00%121.27M
4.03%121.12M
2.95%119.51M
2.95%119.51M
8.07%119.05M
4.42%117.74M
-5.12%116.43M
2.66%116.08M
2.66%116.08M
Gains losses not affecting retained earnings
0.00%-1.74M
0.00%-1.74M
7.99%-1.74M
13.30%-1.74M
13.30%-1.74M
---1.74M
---1.74M
---1.89M
2.34%-2.01M
2.34%-2.01M
Total stockholders'equity
471.58%10M
-2.42%-7.28M
-6.36%-5.12M
-159.60%-4.57M
-159.60%-4.57M
-202.52%-2.69M
-652.67%-7.11M
-194.63%-4.81M
-279.23%-1.76M
-279.23%-1.76M
Total equity
471.58%10M
-2.42%-7.28M
-6.36%-5.12M
-159.60%-4.57M
-159.60%-4.57M
-202.52%-2.69M
-652.67%-7.11M
-194.63%-4.81M
-279.23%-1.76M
-279.23%-1.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -83.78%1.03M-59.02%3.08M-55.31%4.83M-65.40%4.87M-65.40%4.87M-22.99%6.36M-34.02%7.51M-29.73%10.8M-18.99%14.08M-18.99%14.08M
-Cash and cash equivalents -83.78%1.03M-59.02%3.08M-55.31%4.83M-65.40%4.87M-65.40%4.87M-22.99%6.36M-34.02%7.51M-29.73%10.8M-18.99%14.08M-18.99%14.08M
Receivables 96.49%448K221.01%443K142.02%288K232.73%366K232.73%366K13.97%228K-23.46%138K-38.85%119K12.24%110K12.24%110K
-Accounts receivable --120K--119K--------------------------------
-Other receivables 43.86%328K134.78%324K142.02%288K232.73%366K232.73%366K13.97%228K-23.46%138K-38.85%119K12.24%110K12.24%110K
Prepaid assets ------------57.78%71K57.78%71K-------------80.26%45K-80.26%45K
Restricted cash 12.30%137K9.52%138K10.24%140K0.00%140K0.00%140K--122K--126K--127K-2.10%140K-2.10%140K
Total current assets -75.91%1.62M-52.93%3.66M-52.43%5.25M-62.09%5.45M-62.09%5.45M-20.67%6.71M-32.77%7.77M-29.03%11.05M-19.46%14.37M-19.46%14.37M
Non current assets
Net PPE -10.33%10.64M-7.69%11.19M-3.67%11.8M-5.29%12.03M-5.29%12.03M-2.95%11.87M-5.33%12.13M-13.63%12.25M-10.54%12.7M-10.54%12.7M
-Gross PPE -10.33%10.64M-7.69%11.19M-3.67%11.8M-1.89%14.83M-1.89%14.83M-2.95%11.87M-5.33%12.13M-13.63%12.25M-7.39%15.12M-7.39%15.12M
-Accumulated depreciation -------------15.99%-2.81M-15.99%-2.81M-------------13.61%-2.42M-13.61%-2.42M
Total non current assets -10.33%10.64M-7.69%11.19M-3.67%11.8M-5.29%12.03M-5.29%12.03M-5.06%11.87M-7.35%12.13M-15.37%12.25M-10.54%12.7M-10.54%12.7M
Total assets -34.02%12.26M-25.36%14.85M-26.79%17.05M-35.45%17.47M-35.45%17.47M-11.36%18.58M-19.27%19.9M-22.45%23.29M-15.51%27.07M-15.51%27.07M
Liabilities
Current liabilities
Payables -11.07%1.03M-12.45%1.31M-28.76%1.54M-25.28%535K-25.28%535K27.05%1.16M31.16%1.49M-10.81%2.16M-28.33%716K-28.33%716K
-accounts payable -21.25%430K1.08%658K-29.32%928K-25.28%535K-25.28%535K84.64%546K9.88%651K1.82%1.31M-28.33%716K-28.33%716K
-Other payable -1.97%598K-22.89%650K-27.90%610K---------0.68%610K54.21%843K-25.21%846K--------
Current accrued expenses -------------31.53%849K-31.53%849K------------15.89%1.24M15.89%1.24M
Current debt and capital lease obligation -4.71%364K-7.61%364K-7.86%387K3.66%396K3.66%396K-31.96%382K-93.01%394K66.58%420K1.87%382K1.87%382K
-Current capital lease obligation -4.71%364K-7.61%364K-7.86%387K3.66%396K3.66%396K19.64%382K59.63%394K66.58%420K1.87%382K1.87%382K
Current liabilities -9.49%1.39M-11.44%1.67M-25.36%1.93M-23.87%1.78M-23.87%1.78M4.53%1.54M-72.13%1.89M-3.51%2.58M-4.34%2.34M-4.34%2.34M
Non current liabilities
Long term debt and capital lease obligation -95.56%863K-15.52%20.46M-11.45%20.24M-4.70%20.17M-4.70%20.17M15.35%19.43M46.27%24.22M2.74%22.86M-26.04%21.16M-26.04%21.16M
-Long term debt -98.49%280K-14.91%19.82M-10.71%19.51M-3.56%19.37M-3.56%19.37M19.70%18.6M55.66%23.29M6.63%21.85M-26.07%20.08M-26.07%20.08M
-Long term capital lease obligation -29.16%583K-30.96%640K-27.38%732K-26.07%797K-26.07%797K-36.63%823K-41.86%927K-42.59%1.01M-25.45%1.08M-25.45%1.08M
Derivative product liabilities -99.04%3K-99.67%3K--0-98.20%96K-98.20%96K--311K--902K--2.66M--5.33M--5.33M
Total non current liabilities -95.61%866K-18.54%20.46M-20.69%20.24M-23.51%20.26M-23.51%20.26M17.02%19.74M51.47%25.12M14.56%25.52M-7.41%26.49M-7.41%26.49M
Total liabilities -89.39%2.26M-18.05%22.14M-21.12%22.17M-23.54%22.04M-23.54%22.04M16.01%21.27M15.63%27.01M12.63%28.1M-7.17%28.83M-7.17%28.83M
Shareholders'equity
Share capital --5.63M--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock --5.63M------------------------------------
Retained earnings 3.91%-115.31M-3.01%-126.82M-4.31%-124.49M-5.61%-122.34M-5.61%-122.34M-11.59%-120.01M-10.44%-123.11M-1.46%-119.35M-5.27%-115.84M-5.27%-115.84M
Paid-in capital 1.99%121.43M3.00%121.27M4.03%121.12M2.95%119.51M2.95%119.51M8.07%119.05M4.42%117.74M-5.12%116.43M2.66%116.08M2.66%116.08M
Gains losses not affecting retained earnings 0.00%-1.74M0.00%-1.74M7.99%-1.74M13.30%-1.74M13.30%-1.74M---1.74M---1.74M---1.89M2.34%-2.01M2.34%-2.01M
Total stockholders'equity 471.58%10M-2.42%-7.28M-6.36%-5.12M-159.60%-4.57M-159.60%-4.57M-202.52%-2.69M-652.67%-7.11M-194.63%-4.81M-279.23%-1.76M-279.23%-1.76M
Total equity 471.58%10M-2.42%-7.28M-6.36%-5.12M-159.60%-4.57M-159.60%-4.57M-202.52%-2.69M-652.67%-7.11M-194.63%-4.81M-279.23%-1.76M-279.23%-1.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data